SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001390478-17-000020
Filing Date
2017-03-15
Accepted
2017-03-15 16:28:58
Documents
100
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K gale-20161231x10xk.htm 10-K 2036504
2 EXHIBIT 3.1 gale-20161231xex31.htm EX-3.1 411130
3 EXHIBIT 3.3 gale-20161231xex34.htm EX-3.3 417647
4 EXHIBIT 4.1 rxipc0211916.htm EX-4.1 12897
5 EXHIBIT 21.1 gale-20161231xex211.htm EX-21.1 3572
6 EXHIBIT 23.1 gale-20161231xex231.htm EX-23.1 3270
7 EXHIBIT 31.1 gale-20161231xex311.htm EX-31.1 9002
8 EXHIBIT 32.1 gale-20161231xex321.htm EX-32.1 5039
15 coiimage.jpg GRAPHIC 13272
16 logo-verticala14.jpg GRAPHIC 21485
17 logo-verticala15.jpg GRAPHIC 21485
18 partnerchart020717.jpg GRAPHIC 49920
19 performancechartv2.jpg GRAPHIC 79428
20 pipeline21027.jpg GRAPHIC 38695
21 rxipc0211916001.jpg GRAPHIC 475127
22 rxipc0211916002.jpg GRAPHIC 214251
  Complete submission text file 0001390478-17-000020.txt   11926178

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT gale-20161231.xml EX-101.INS 1998719
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20161231.xsd EX-101.SCH 90031
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20161231_cal.xml EX-101.CAL 117208
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20161231_def.xml EX-101.DEF 365526
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20161231_lab.xml EX-101.LAB 1025325
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20161231_pre.xml EX-101.PRE 586681
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 17691634
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences